To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Environment.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H905175FB33F04CF5802328233F006D1D: 1. Short title This Act may be cited as the 340B Transparency Act.
- Section HD856A0F20438494995F3FD8872B2FCDD: 2. Ensuring transparency and oversight of the 340B drug discount program Section 340B(a)(5) of the Public Health Service Act (42 U.S.C. 256b(a)(5)) is amended—...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Government Operations, Environment
Primary Purpose
This bill, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
ReportedReported with an amendment, committed to the Committee of the …
Mr. Bucshon introduced the following bill; which was referred to …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
Key Definitions
Terms defined in this bill
a department of a provider (as defined in section 413.65 of title 42, Code of Federal Regulations, or any successor regulation) that is not located— on the campus (as defined in such section) of such provider
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology